Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS. DICLOFENAC SODIUM and MISOPROSTOL delayed-release tablets, for oral use Initial U.S. Approval:1997
Medication labelWhy this: Advisory · dailymed-prescription
Diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. For a list of factors that may increase the risk of NSAID-induced gastric and duodenal ulcers and their complications [see Warnings and Precautions (5.2)].
- generic_name
- diclofenac sodium and misoprostol
- product_names
- Diclofenac Sodium and Misoprostol
- ndc
- 71205-865, 71205-866, 75834-264, 71205-865-30, 71205-865-60, 71205-865-90, 71205-865-00, 71205-865-72, 71205-865-64, 71205-865-55, 75834-265, 71205-866-30, 71205-866-60, 71205-866-90, 71205-866-00, 71205-866-72, 71205-866-64, 71205-866-55
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en